These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children. Woolf AD, Wenger T, Smith TW, Lovejoy FH. N Engl J Med; 1992 Jun 25; 326(26):1739-44. PubMed ID: 1594015 [Abstract] [Full Text] [Related]
3. [Suicidal digitalis poisoning: considerations concerning treatment strategy with antibodies]. Hess T, Zeugin T, Weiss M. Schweiz Med Wochenschr; 1989 Oct 21; 119(42):1466-9. PubMed ID: 2814412 [Abstract] [Full Text] [Related]
4. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. Smith TW, Butler VP, Haber E, Fozzard H, Marcus FI, Bremner WF, Schulman IC, Phillips A. N Engl J Med; 1982 Nov 25; 307(22):1357-62. PubMed ID: 6752715 [Abstract] [Full Text] [Related]
11. [Digitoxin-induced thrombocytopenia]. Gschwantler M, Gulz W, Brownstone E, Feichtenschlager T, Pulgram T, Schrutka-Kölbl C, Weiss W. Wien Klin Wochenschr; 1993 Nov 25; 105(17):500-2. PubMed ID: 8212711 [Abstract] [Full Text] [Related]
12. Digoxin-specific Fab fragments as single first-line therapy in digitalis poisoning. Lapostolle F, Borron SW, Verdier C, Taboulet P, Guerrier G, Adnet F, Clemessy JL, Bismuth C, Baud FJ. Crit Care Med; 2008 Nov 25; 36(11):3014-8. PubMed ID: 18824911 [Abstract] [Full Text] [Related]
13. [Digitoxin poisoning: reversing ventricular fibrillation with Fab fragments of anti-digoxin antibody]. Domart Y, Bismuth C, Schermann JM, Abuaf N, Pontal PG, Baud F, Bolo A, Gailliot M, Fournier PE. Nouv Presse Med; 1982 Dec 25; 11(52):3827-30. PubMed ID: 7162976 [Abstract] [Full Text] [Related]
14. [Thrombocytopenia in digitoxin poisoning]. Schneider AW, Gilfrich HJ, Fechler L. Dtsch Med Wochenschr; 1992 Feb 28; 117(9):337-40. PubMed ID: 1544354 [Abstract] [Full Text] [Related]
15. [Reversibility of severe digitoxin poisoning with antidigoxin antibodies]. Domart Y, Bismuth C, Pontal PG, Scherrmann JM, Baud F, Muszynski J, Elkhouly M, Fournier PE. Ann Med Interne (Paris); 1983 Feb 28; 134(6):555-8. PubMed ID: 6651078 [Abstract] [Full Text] [Related]
16. Immunopharmacological activity of monoclonal antidigitoxin. Urtizberea M, Latour M, Edelman L, Carcagne J, Armand J, Scherrmann JM. Dev Biol Stand; 1990 Feb 28; 71():147-57. PubMed ID: 2401380 [Abstract] [Full Text] [Related]
17. [Immunopharmacologic treatment of 9 digitalis poisonings in children with sheep antidigoxin Fab]. Smolarz A, Abshagen U. Monatsschr Kinderheilkd; 1985 Sep 28; 133(9):682-7. PubMed ID: 4058431 [Abstract] [Full Text] [Related]
18. Use of cholestyramine resin in the treatment of digitoxin toxicity. Cady WJ, Rehder TL, Campbell J. Am J Hosp Pharm; 1979 Jan 28; 36(1):92-4. PubMed ID: 758792 [Abstract] [Full Text] [Related]
19. Digitoxin intoxication with lethal outcome. Krappweis J, Petereit G, Justus J, Altmann E, Kirch W. Eur J Med Res; 1996 Nov 25; 1(12):551-3. PubMed ID: 9438160 [Abstract] [Full Text] [Related]
20. Use of cholestyramine in three patients with beta-acetyldigoxin, beta-methyldigoxin and digitoxin intoxication. Kuhlmann J. Int J Clin Pharmacol Ther Toxicol; 1984 Oct 25; 22(10):543-8. PubMed ID: 6511130 [Abstract] [Full Text] [Related] Page: [Next] [New Search]